The American Conference Institute’s FDA Boot Camp has prepared life science attorneys and executives to master the fundamentals of FDA regulation for more than 15 years. At the 36th iteration of this conference, WilmerHale Partner Emily Whelan will lead an in-depth workshop, “Hatch-Waxman and BPCIA in the Trenches: Exclusivity and Bioequivalency Working Group.”
We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.
